ZILOSUL: Pentosan Polysulfate Sodium - Emerging Drug Insights and Market Forecast 2019-2023 & 2023-2032 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, Canada, and Korea
November 22, 2023 08:53 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "ZILOSUL Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Ampreloxetine: An Investigational, Once-Daily Norepinephrine Reuptake Inhibitor - Emerging Drug Insights and Market Forecasts to 2032: Focus on United States, Germany, France, Italy, Spain UK, & Japan
September 11, 2023 04:23 ET
|
Research and Markets
Dublin, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The "Ampreloxetine Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report...
RPL554: A First-in-Class, Inhaled, Dual Inhibitor of the PDE3 and PDE4 Enzymes, and Verona Pharma's Lead Pipeline Asset - Emerging Drug Insights and Market Forecasts 2019-2023 & 2023-2032
August 03, 2023 06:58 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "RPL554 Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. The report offers...
Pitolisant: A Selective Histamine 3 (H3) Receptor Antagonist/Inverse Agonist - Emerging Drug Insight and Market Forecasts, 2019-2023 & 2023-2032
August 03, 2023 06:53 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Pitolisant Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report offers a...
AMO-02 Emerging Drug Insights and Market Forecasts, 2032: Focus on 7 Major Markets - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
August 03, 2023 06:48 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "AMO-02 Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. The report offers...
Nedosiran Emerging Drug Insight and Market Forecasts, 2032: Focus on 7 Major Markets - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
August 03, 2023 06:43 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Nedosiran Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. The report presents...
Avexitide: A 31-amino Acid Peptide that Selectively Targets and Blocks GLP-1 Receptors - Emerging Drug Insights and Market Forecasts, 2019-2022 & 2023-2032
August 01, 2023 06:28 ET
|
Research and Markets
Dublin, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The "Avexitide Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. "Avexitide Emerging...
Latozinemab (AL001): Alector's Wholly-owned Humanized Recombinant Monoclonal Antibody - Emerging Drug Insights and Market Forecasts 2019-2022 & 2023-2032
April 13, 2023 10:48 ET
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Latozinemab (AL001) Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report provides...
Zilucoplan: A Selective C5 (Complement Component 5) Peptide Inhibitor Under Clinical Development by UCB Biopharma - Emerging Drug Insight and Market Forecasts to 2032
April 13, 2023 10:44 ET
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Zilucoplan Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report provides...
Zunsemetinib (ATI-450) Emerging Drug Insights and Market Forecasts, 2032
April 13, 2023 10:33 ET
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report...